Dr. David Straus: Emerging Developments in Hodgkin's Lymphoma

OncologySTAT Editorial Team. 2011 Jul 27, Interview by L Scott Zoeller

Abstract

David Straus, MD, is Attending Physician, Lymphoma Service, Memorial Sloan-Kettering Cancer Center in New York. OncologySTAT: Dr. Straus, would you discuss how prognosis and treatment have evolved over the past few decades for patients with Hodgkin’s lymphoma (HL)? Would you talk about the use of chemotherapy and also the role of radiation therapy for patients with early- vs late-stage disease?Dr. Straus: Radiation oncology provided the first real breakthrough in treatment in the 1930s, when a Swiss...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration